Tympulse Medical will be attending the 23rd International Symposium on Recent Advances in Otitis Media (June 16th-18th) at the Children's Hospital of Philadelphia, where we will be discussing our innovative work on Tympanic Membrane regeneration and repair, carried out in partnership with Fergal O'Brien and the RCSI Tissue Engineering Research Group (TERG). Thanks to long-time clinical collaborator Joe Kerschner and his team at Medical College of Wisconsin for supporting our work and driving this innovation closer to clinical reality!
About us
Tympulse Medical, a High Potential Start Up company, spun out of the Royal College of Surgeons in Ireland, is commercialising TympanoColl, a highly innovative and disruptive approach to the repair of the Ear Drum (Tympanic Membrane or TM). With our unique delivery system, TympanoColl has the potential to transform the “Gold Standard” approach to TM repair, reducing procedure times by repairing the ear drum via the ear canal in an outpatient setting.
- Website
-
www.tympulsemed.com
External link for Tympulse Medical
- Industry
- Medical Equipment Manufacturing
- Company size
- 2-10 employees
- Headquarters
- Dublin
- Type
- Privately Held
- Founded
- 2022
Locations
-
Primary
Get directions
Dublin, IE
Employees at Tympulse Medical
Updates
-
Pretty proud this week! Really humbled to be 1 of the 8 standout companies selected for the 2025 cohort (from 170 applicants)!!! Testament to the hard graft by the original innovators of this technology from RCSI Tissue Engineering Research Group (TERG) & Medical College of Wisconsin - Fergal O'Brien, Joe Kerschner, Cian O'Leary, Andrew Cameron, Ronaldo José Farias Corrêa do Amaral, Eamon Sheehy, Elizabeth Sainsbury, Cian O'Connor, Derek John & Prof Alexander Blayney
-
-
Shout-out and thanks to Emer Sherry and Irish Medtech team for hosting Tympulse Medical at Medtech Connect+ last year! 1st time attending & already within the 1st month of 2025, it has legitimately linked us with (i) a new contract manufacturing partner we hadn't met, (ii) an investor introduction with a fund we previously thought were not a fit at our stage of funding, (iii) a legal expert in M&As that has already helped us out and (iv) boosted our profile beyond the Island with International partners contacting us directly!!! Can't wait till next year!
-
-
So grateful to be invited to pitch with some really impressive Medtech startups! Best of luck to Aamir Hameed Donald Hickey & Darragh Colgan, and Judi O' Malley
The Medtech Connect+ finalists pitching at #MedtechRising are, Brian Ledwith, AVeta Medical; Jason Mowles, CergenX; Eddie McDaid, Galenband; Darragh Colgan, Pumpinheart; Judi O' Malley, Spiorad Medical Limited ; and Dr John Gleeson, Tympulse Medical. The winning company will be presented with an award and offered the opportunity to deliver a showcase on the main stage. Additionally, the winners will receive tickets to pitch at the Medtech Strategist Conference in April 2025 (valued at >€4,000), a prize kindly sponsored by Seroba.
-
-
-
-
-
+1
-
-
What a Friday!!! We also just received word that Tympulse Medical, aspin out from RCSI Tissue Engineering Research Group (TERG), has just been accepted into the TMC Innovation's 18th cohort, selected after a diligence bootcamp, starting January 2025!! Texas Medical Center Innovation Factory accelerator programs bring innovative entrepreneurs and companies from around the world to the TMC Innovation Factory in Houston, connecting them with researchers and experts from across TMC’s campuses to solve unmet clinical needs and reach the next business milestone. The HealthTech Accelerator is a six-month program that supports digital health and medical device startups by bringing together experts from different markets to create real-life solutions, enhance clinical collaborations, increase fundraising opportunities, and create relationships with the TMC Medical Campuses network of institutions.
-
-
Delighted to announce that Tympulse Medical has just been announced as 1 of the 5 Finalists for the Medtech Connect+ showcase 2024, along with our RCSI Tissue Engineering Research Group (TERG) colleague Aamir Hameed from Pumpinheart!!!
Alongside Enterprise Ireland and IDA Ireland today Irish Medtech are delighted to reveal the finalists of the Irish Medtech Awards 2024, which are held as part of Medtech Rising, 05 December, in The Galmont, Galway. Finalists 2024: Medtech Company of the Year: Arrotek Medical Ltd, Deciphex, and Freudenberg Medical Emerging Medtech Company of the Year: ICS Medical Devices, LUMA Vision and Tympany Medical Sustainable Medtech Company of the Year: Boston Scientific Clonmel, Stryker Ireland, and Zimmer Biomet Digital Health Innovation of the Year: Deciphex, Galenband, and Head Diagnostics Best Process-Product Innovation in Medtech: Alcon Ireland, Boston Scientific Cork, and Harmac Medical Products Collaboration in Medtech Award: Atlantic Technological University (M.Sc. & Postgrad. Cert. in End-to-End Sterility Assurance), Deciphex & Novartis Ireland (Advancing AI in Preclinical Studies), and University of Galway & Medtronic Signature Innovation Partnership Medtech Partner/Supplier of the Year: Arrotek Medical Ltd, Freudenberg Medical, and Lawrence Engineering Ltd Best Talent Strategy in Medtech: BD Research Centre Ireland, Johnson & Johnson MedTech, and Zimmer Biomet Best Diversity and Representation Initiative in Medtech: Boston Scientific Galway, Mergon Group, and Stryker Ireland I’d like to congratulate all those who have stood out as finalists, as well as thank all those who submitted entries making this the most competitive Irish Medtech Awards yet. Finalists for the Medtech Connect+ showcase 2024 have also been revealed today. Medtech Connect+ takes place at Medtech Rising and provides high potential start-ups with a platform to raise awareness and present their innovative technology solutions to potential business partners or investors. Medtech Connect+ Finalists: Pumpinheart, Spiorad Medical Limited , CergenX, Tympulse Medical, Galenband, AVeta Medical. The winners will be announced at Medtech Rising, 05 December, in The Galmont Hotel, Galway. For further details on how to book your place at Medtech Rising this year - please visit: www.medtechrising.ie
-
Had an amazing week at the Texas Medical Center Innovation Factory, pitching to the subject matter experts and getting US-focused feedback on Tympulse Medical's new concept for outpatient ear drum repair. Not even a broken collarbone could make me miss this opportunity!
-
-
Tympulse Medical has had a fantastic 2024, globetrotting to grow our executive & advisory team. We capped it off with a trip to the biggest ENT conference in the world in Miami! #OTOMTG24. Thanks to everyone in RCSI Innovation, RCSI Tissue Engineering Research Group (TERG), & Enterprise Ireland for supporting us on our journey to bring TympanoColl closer to the clinic. With a growing international group of Key Opinion Leading (KOL) ENT surgeons joining us on our journey this year, can't wait to see where 2025 takes us!
-
-
Great couple of days attending the EU Otorhinolaryngology – Head & Neck Surgery (EU ORL-HNS 24) conference in the The Convention Centre Dublin (The CCD). The unmet need for a minimally invasive solution like TympanoColl could not be clearer. Thanks to our clinical partners & new commercial collaborators for the validation & strong support! See you all at AAO-HNSF 2024 in Miami!
-